Sintx Technologies, Inc.

NASDAQ: SINTHealthcare / Medical Appliances & Equipment / USA
0.120000.00Vol 6 132 5981Y Perf -89.13%
Jun 14th, 2019 15:59
BID0.1100 ASK0.1200
Open0.1200 Previous Close0.1200
Pre-Market- After-Trading-
 - -%  - -%
Target Price
4.35 
Analyst Rating
— — 0.00
Potencial %
3 525.00 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)3 
Earnings Rating
Price Range Ratio 52wk %
0.94 
Earnings Date
21st May 2019

Today's Price Range

0.12000.1300

52wk Range

0.11001.17

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
-33.33%
3 Months
-47.83%
6 Months
-47.83%
1 Year
-89.13%
3 Years
-
5 Years
-

Name / TickerPriceChg.Chg.%
SINT0.12000.00000.00
AAPL192.74-1.4100-0.73
GOOG1 085.35-3.4200-0.31
MSFT132.450.13000.10
XOM74.35-0.3300-0.44
WFC45.590.30000.66
JNJ140.09-0.6200-0.44
FB181.333.86002.18
GE10.23-0.0800-0.78
JPM109.820.28000.26
Earnings HistoryEstimateReportedSurprise %
Q03 2018--0.11-
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume6 132 598
Shares Outstanding (in ths.)21 793
Trades Count3 886
Dollar Volume666 492
Avg. Volume1 288 831
Avg. Weekly Volume23 092 914
Avg. Monthly Volume6 042 854
Avg. Quarterly Volume2 074 873
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Rating---

Sintx Technologies, Inc.

SINTX Technologies Inc is a commercial biomaterial company, focuses on using its silicon nitride technology platform to develop, manufacture and sell a range of medical devices. It is also engaged in developing wear- and corrosion-resistant implant components for hip and knee arthroplasty. The company markets and sells its products to surgeons and hospitals directly, as well as through a network of independent sales distributors. It derives its revenue primarily from the sale of spinal fusion and fixation devices and related products used in the treatment of spine disorders.

CEO: B. Sonny Bal

Teplephone: +1 801 839-3500

Address: 1885 West 2100 South, Salt Lake City 84119, UT, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

60%40%

Bearish Bullish

25%75%

Bearish Bullish

33%67%

News